Inhibitor of inflammatory conditions
AssigneeCompton Developments Ltd.
InventorsEmma Jane Blain, Victor Collin Duance, Ahmed Yasine Ali, Ifor Delme Bowen
Life of this patent
Estimating the term…
Abstract
The invention relates to Boswellia frereana and particularly an extract of same for treating a range of inflammatory disorder or conditions selected from the group comprising: inflammatory bowel disease (IBD), all forms of muscular dystrophy especially Duchenne muscular dystrophy, sepsis, sepsis syndrome, osteoporosis, ischemic injury, graft vs. host disease, reperfusion injury, asthma, diabetes, cancer, myelogenous and other leukemias, psoriasis and cachexia, Alzheimer's Disease, demyelinating neurological disorders including multiple sclerosis, acetylcholinesterase mediated disorders, retinal disorders, neurological, retinal, and muscular disorders.
Claims10
A method of treating a disorder or condition selected from the group consisting of inflammatory bowel disease (IBD), breast cancer, inflammation, and a combination thereof in a patient in need thereof, comprising administering to said patient an effective amount of an alcohol extract of Boswellia frereana, wherein said extract comprises epi-lupeol or a salt thereof, and wherein the extract is devoid of boswellic acids.
A method of treating a disorder or condition selected from the group consisting of inflammatory bowel disease (IBD), breast cancer, inflammation, and a combination thereof in a patient in need thereof, comprising administering to said patient:
- a. an effective amount of an alcohol extract of Boswellia frereana, wherein said extract comprises epi-lupeol or a salt thereof, and wherein the extract is devoid of boswellic acids;
- b. a composition comprising an effective amount of an alcohol extract of Boswellia frereana, wherein said extract comprises epi-lupeol or a salt thereof, and wherein the extract is devoid of boswellic acids;
- or
- c. a combination therapeutic comprising:
- i.) an effective amount of an alcohol extract of Boswellia frereana, wherein said extract comprises epi-lupeol or a salt thereof, and wherein the extract is devoid of boswellic acids;
- and
- ii.) an additional therapeutic.
Dependencies are inferred from the claim text.